Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAston Martin Lagonda Regulatory News (AML)

Share Price Information for Aston Martin Lagonda (AML)

Share Price is delayed by 15 minutes
Get Live Data
41.12    -1.44 (-3.38%)
Bid:
41.06
Ask:
43.48
Spread: 2.42 (5.894%)
Market Cap: £416.42m
AML Live PriceLast checked at - London Stock Exchange

Intraday Aston Martin Lagonda Share Chart

Director/PDMR Shareholding

15 Dec 2020 09:30

RNS Number : 6919I
Aston Martin Lagonda Global Hld PLC
15 December 2020
 

15 December 2020

Aston Martin Lagonda Global Holdings plc

Notification of transactions by Directors, Persons Discharging Managerial Responsibilities ("PDMRs") and persons closely associated with them

Aston Martin Lagonda Global Holdings plc (the "Company") announces the following changes in the interests of Directors in the Ordinary Shares in the Company ("Shares"), which took place on 14 December 2020.

In accordance with the rules of the Aston Martin Lagonda Long-Term Incentive Plan 2018 ("LTIP"), the Directors named below were granted nil-cost options over Shares as follows:

· Tobias Moers (CEO) - 211,618 shares (300% of salary)

· Kenneth Gregor (CFO) - 70,539 shares (200% of salary)

The LTIP awards are the 2020 grant which was delayed due to the unprecedented uncertainty and change faced during 2020 (both specifically for the Company and externally due to Covid-19). The Remuneration Committee were able to determine the most appropriate approach and approved the 2020 LTIP grant at its October 2020 meeting, once the new leadership team and an updated business plan were established. The LTIP awards were granted at the first opportunity post this approval, following the General Meeting held on 4 December 2020 and on the first dealing day of the consolidated shares.

These LTIP awards are subject to the performance conditions, performance periods, vesting periods and malus and clawback provisions set out below, in-line with the Remuneration Policy approved in 2019. The targets related to Adjusted EBITDA performance remain commercially sensitive at this point and will be set out in the 2020 Directors' Remuneration Report which is expected to be published in March 2021, along with full details of the LTIP awards.

2020 Performance measures

2020 LTIP targets

Vesting*(as a % of maximum)

Adjusted EBITDA

(80% of award)

Threshold

EBITDA targets remain commercially sensitive and will be disclosed in the 2020 DRR

20%

Stretch

80%

Maximum

100%

Relative TSR

(vs. luxury peers)(20% of award)

Threshold

Rank 6th (median)

20%

Maximum

Rank 3rd or above(80th percentile)

100%

* Vesting will be on a straight-line basis between each of threshold and stretch, and stretch and maximum for the EBITDA element and threshold and maximum for the TSR element

· TSR performance will be measured on a ranked basis against the following luxury companies: Burberry, Capri Holdings, Compagnie Financiere Richemont, Ferrari, Hermes International, Kering, LVMH, Moncler, Prada and Ralph Lauren.

· The Remuneration Committee retains discretion to adjust the vesting levels to ensure they reflect underlying business performance and any other relevant factors to ensure that the value at vesting is fully reflective of the performance delivered and executives do not receive unjustified windfall gains.

Performance period

· The period over which the EBITDA performance condition will be measured is from 1 January 2020 to 31 December 2022 (three financial years).

· The period over which the TSR performance condition will be measured is from 14 December 2020 to 13 December 2023 (three years from grant date).

Vesting period

· Subject to performance, the element of awards subject to EBITDA performance will vest following the announcement of results for 2022 (early March 2023).

· Subject to performance, the element of awards subject to relative TSR performance will vest three years from grant, following the Remuneration Committee's determination of the performance outcome.

· The CEO and CFO will be required to hold at least 75% of any shares that vest (net of tax) until they have met their shareholding guidelines under the shareholding policy.

 

Malus and Clawback:

· Malus and clawback provisions will be operated at the discretion of the Remuneration Committee in respect of awards granted under the LTIP where it considers that there are exceptional circumstances. Such exceptional circumstances may include serious reputational damage, a failure of risk management, an error in available financial information, which led to the award being greater than it would otherwise have been or personal misconduct.

· Clawback may be applied for a period of up to three years for any LTIP awards.

 

 

 

Enquiries:

 

Investors and Analysts

Charlotte Cowley,

Director of Investor Relations

 

 

+44 (0)7771 976764

charlotte.cowley@astonmartin.com

Media

Kevin Watters,

Director of Communications

 

 

 +44 (0)7764 386683

kevin.watters@astonmartin.com

Grace Barnie,

Corporate Communications Manager

 

 +44 (0)7880 903490

grace.barnie@astonmartin.com

Tulchan Communications

Harry Cameron and Simon Pilkington

 

+44 (0)20 73534200

 

 

Notification of transactions by Directors, Persons Discharging Managerial Responsibilities ("PDMRs") and persons closely associated with them

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Tobias Moers

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Aston Martin Lagonda Global Holdings plc

b)

LEI

213800167WOVOK5ZC776

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrumentIdentification code

Ordinary Shares (ISIN: GB00BN7CG237)

 

 

b)

Nature of the transaction

Grant of 2020 LTIP awards

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£12.05

211,618

d)

Aggregated information- Aggregated volume

- Price

211,618

£2,549,996.90

e)

Date of the transaction

14 December 2020

f)

Place of the transaction

London

Notification of transactions by Directors, Persons Discharging Managerial Responsibilities ("PDMRs") and persons closely associated with them

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Kenneth Gregor

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Aston Martin Lagonda Global Holdings plc

b)

LEI

213800167WOVOK5ZC776

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrumentIdentification code

Ordinary Shares (ISIN: GB00BN7CG237)

 

 

b)

Nature of the transaction

Grant of 2020 LTIP awards

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£12.05

70,539

d)

Aggregated information- Aggregated volume

- Price

70,539

£849,994.95

e)

Date of the transaction

14 December 2020

f)

Place of the transaction

London

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGCBDDGDBDGGU
Date   Source Headline
4th Jun 20267:00 amRNSIssue of equity to satisfy share awards
15th May 20267:00 amRNSIssue of equity to satisfy employee share awards
6th May 202612:51 pmRNSVoting results of AGM 2026
29th Apr 20267:00 amRNSQ1 results for three months ended 31 March 2026
25th Mar 20269:53 amRNSAnnual Financial Report
9th Mar 202612:12 pmRNSResult of Meeting
25th Feb 20267:00 amRNSPreliminary Results FY2025
20th Feb 20267:00 amRNSNotice of GM and FY 2025 Trading Update
29th Oct 20257:00 amRNSQ3 results for the quarter ended 30 September 2025
6th Oct 20257:00 amRNSQ3 2025 Trading Update and revised outlook
10th Sep 202511:33 amRNSDirector/PDMR Shareholding
5th Sep 20257:00 amRNSIssue of equity to satisfy employee share awards
30th Jul 20257:00 amRNSInterim results
28th Jul 20254:33 pmRNSDirectorate Change
27th May 202510:13 amRNSDirector/PDMR Shareholding
27th May 202510:12 amRNSDirector/PDMR Shareholding
15th May 202510:38 amRNSHolding(s) in Company
13th May 20255:26 pmRNSHolding(s) in Company
13th May 202510:33 amRNSDirector/PDMR Shareholding
13th May 202510:31 amRNSDirector/PDMR Shareholding
13th May 202510:26 amRNSDirector/PDMR Shareholding
12th May 20255:53 pmRNSHolding(s) in Company
12th May 20251:13 pmRNSHolding(s) in Company
12th May 202512:52 pmRNSHolding(s) in Company
7th May 20252:45 pmRNSDirector/PDMR Shareholding
7th May 20251:15 pmRNSResult of General Meeting and issue of equity
7th May 20251:07 pmRNSVoting Result of AGM
30th Apr 20257:00 amRNS1st Quarter Results
17th Apr 20258:57 amRNSNotice of General Meeting
16th Apr 20253:20 pmRNSDirector Declaration
31st Mar 20255:11 pmRNSStatement regarding media comments
31st Mar 20257:00 amRNSProposed investment by Yew Tree Consortium
26th Mar 20259:24 amRNSAnnual Financial Report
26th Feb 20257:00 amRNSPreliminary results year ended 31 December 2024
25th Feb 202510:00 amRNSIndependent Non-executive Director appointment
7th Feb 20255:29 pmRNSHolding(s) in Company
13th Dec 20249:00 amRNSDirectorate Change
4th Dec 20244:00 pmRNSHolding(s) in Company
29th Nov 20244:15 pmRNSHolding(s) in Company
29th Nov 20241:01 pmRNSHolding(s) in Company
29th Nov 202412:46 pmRNSDirector/PDMR Shareholding Replacement
29th Nov 202412:18 pmRNSDirector/PDMR Shareholding
29th Nov 202412:17 pmRNSDirector/PDMR Shareholding
29th Nov 202412:11 pmRNSDirector/PDMR Shareholding
27th Nov 20247:00 amRNSResult of Equity Issue
26th Nov 20245:06 pmRNSIssue of Equity
26th Nov 20244:58 pmRNSIssue of Equity
6th Nov 202410:37 amRNSDirector/PDMR Shareholding
30th Oct 20247:00 amRNS3rd Quarter Results
30th Sep 20247:00 amRNSTrading Update and adjustment to FY 2024 guidance

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.